dasatinib 50 MG Oral Tablet

RxCUI
643107
RxNorm name
dasatinib 50 MG Oral Tablet
Display name
dasatinib 50 MG Oral Tablet
Full name
dasatinib 50 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DASATINIBDASATINIBNorthStar RxLLCf9b79d54-9bee-4c93-9c87-f3e65d91f1462026-05-28Warnings, Adverse reactionsExact identifier
rxcui: 643107
DasatinibDASATINIBBluePoint Laboratories02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e42026-03-05Warnings, Adverse reactionsExact identifier
rxcui: 643107
DasatinibDASATINIBLupin Pharmaceuticals, Inc.f60261dd-b8ea-4511-bed6-ad6d7f4dd8282026-02-27Warnings, Adverse reactionsExact identifier
rxcui: 643107
DasatinibDASATINIBAvKARE43e078b9-4e0b-edeb-e063-6294a90a75862025-11-18Warnings, Adverse reactionsExact identifier
rxcui: 643107
DASATINIBDASATINIBAlembic Pharmaceuticals Limited645fcf26-1b2f-40c5-881b-8effe02defbd2025-11-12Warnings, Adverse reactionsExact identifier
rxcui: 643107
DASATINIBDASATINIBAlembic Pharmaceuticals Inc.de3215a4-d098-4bc3-ad81-c7c9e34938722025-11-11Warnings, Adverse reactionsExact identifier
rxcui: 643107
PHYRAGODASATINIBCycle Pharmaceuticals Ltd60976d1e-c415-417f-8168-4e07999a72812025-08-23Warnings, Adverse reactionsExact identifier
rxcui: 643107
dasatinibDASATINIBZydus Lifesciences Limited4eed6b7b-a09d-4d2e-a345-968dd68323bc2025-03-04Exact identifier
rxcui: 643107
DasatinibDASATINIBDr.Reddys Laboratories Inceb5ddff2-6521-b461-43ac-80ff8660b20b2025-03-03Warnings, Adverse reactionsExact identifier
rxcui: 643107
DasatinibDASATINIBBiocon Pharma Inc.76e1833c-e105-5a3d-0f01-1330d8cc7ae12025-02-25Warnings, Adverse reactionsExact identifier
rxcui: 643107
dasatinibDASATINIBZydus Pharmaceuticals USA Inc.11703145-29ea-480a-9810-bc70663b783f2024-09-10Warnings, Adverse reactionsExact identifier
rxcui: 643107
DasatinibDASATINIBApotex Corp.2ed87763-f018-abdb-c0ab-daa5e441b3972024-09-04Warnings, Adverse reactionsExact identifier
rxcui: 643107
DasatinibDASATINIBTeva Pharmaceuticals, Inc.3000fd91-1b09-4d72-8522-1ca5e35ed9562024-08-31Warnings, Adverse reactionsExact identifier
rxcui: 643107
DASATINIBDASATINIBAurobindo Pharma Limited58ce42c6-10bd-4bb4-bf89-eae8ed82c3392024-08-03Warnings, Adverse reactionsExact identifier
rxcui: 643107
SPRYCELDASATINIBE.R. Squibb & Sons, L.L.C.4764f37b-c9e6-4ede-bcc2-8a03b7c521df2024-07-31Warnings, Adverse reactionsExact identifier
rxcui: 643107
DasatinibDASATINIBPrasco Laboratories1931e73f-918c-4d69-9543-de9643513d052024-07-09Warnings, Adverse reactionsExact identifier
rxcui: 643107

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
4764f37b-c9e6-4ede-bcc2-8a03b7c521dfdasatinib 50 MG Oral TabletPSN47These highlights do not include all the information needed to use SPRYCEL ® safely and effectively. See full prescribing information for SPRYCEL. SPRYCEL (dasatinib) tablets, for oral use Initial U.S. Approval: 200620240731
4764f37b-c9e6-4ede-bcc2-8a03b7c521dfdasatinib 50 MG Oral TabletSCD47These highlights do not include all the information needed to use SPRYCEL ® safely and effectively. See full prescribing information for SPRYCEL. SPRYCEL (dasatinib) tablets, for oral use Initial U.S. Approval: 200620240731
2ed87763-f018-abdb-c0ab-daa5e441b397dasatinib 50 MG Oral TabletPSN15These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS DASATINIB tablets, for oral use Initial U.S. Approval: 200620240904
2ed87763-f018-abdb-c0ab-daa5e441b397dasatinib 50 MG Oral TabletSCD15These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS DASATINIB tablets, for oral use Initial U.S. Approval: 200620240904
1931e73f-918c-4d69-9543-de9643513d05dasatinib 50 MG Oral TabletSCD10These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. Dasatinib tablets, for oral use Initial U.S. Approval: 200620240709
1931e73f-918c-4d69-9543-de9643513d05dasatinib 50 MG Oral TabletPSN10These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. Dasatinib tablets, for oral use Initial U.S. Approval: 200620240709
eb5ddff2-6521-b461-43ac-80ff8660b20bdasatinib 50 MG Oral TabletSCD9These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS . DASATINIB tablets, for oral use Initial U.S. Approval: 200620250303
eb5ddff2-6521-b461-43ac-80ff8660b20bdasatinib 50 MG Oral TabletPSN9These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS . DASATINIB tablets, for oral use Initial U.S. Approval: 200620250303
f60261dd-b8ea-4511-bed6-ad6d7f4dd828dasatinib 50 MG Oral TabletSCD7These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620260227
f60261dd-b8ea-4511-bed6-ad6d7f4dd828dasatinib 50 MG Oral TabletPSN7These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620260227
de3215a4-d098-4bc3-ad81-c7c9e3493872dasatinib 50 MG Oral TabletPSN7These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS DASATINIB tablets, for oral use Initial U.S. Approval: 200620251111
de3215a4-d098-4bc3-ad81-c7c9e3493872dasatinib 50 MG Oral TabletSCD7These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS DASATINIB tablets, for oral use Initial U.S. Approval: 200620251111
76e1833c-e105-5a3d-0f01-1330d8cc7ae1dasatinib 50 MG Oral TabletPSN7These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620250225
76e1833c-e105-5a3d-0f01-1330d8cc7ae1dasatinib 50 MG Oral TabletSCD7These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620250225
3000fd91-1b09-4d72-8522-1ca5e35ed956dasatinib 50 MG Oral TabletPSN4These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620240831
3000fd91-1b09-4d72-8522-1ca5e35ed956dasatinib 50 MG Oral TabletSCD4These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620240831
60976d1e-c415-417f-8168-4e07999a7281dasatinib 50 MG Oral TabletSCD3These highlights do not include all the information needed to use PHYRAGO safely and effectively. See full prescribing information for PHYRAGO. PHYRAGO TM (dasatinib) tablets, for oral use Initial U.S. Approval: 200620250823
60976d1e-c415-417f-8168-4e07999a7281dasatinib 50 MG Oral TabletPSN3These highlights do not include all the information needed to use PHYRAGO safely and effectively. See full prescribing information for PHYRAGO. PHYRAGO TM (dasatinib) tablets, for oral use Initial U.S. Approval: 200620250823
f9b79d54-9bee-4c93-9c87-f3e65d91f146dasatinib 50 MG Oral TabletPSN2These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS DASATINIB tablets, for oral use Initial U.S. Approval: 200620260528
f9b79d54-9bee-4c93-9c87-f3e65d91f146dasatinib 50 MG Oral TabletSCD2These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS DASATINIB tablets, for oral use Initial U.S. Approval: 200620260528
02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4dasatinib 50 MG Oral TabletPSN2These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620260305
02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4dasatinib 50 MG Oral TabletSCD2These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620260305
43e078b9-4e0b-edeb-e063-6294a90a7586dasatinib 50 MG Oral TabletPSN1Dasatinib Tablets Rx Only These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. Initial U.S. Approval: 200620251118
43e078b9-4e0b-edeb-e063-6294a90a7586dasatinib 50 MG Oral TabletSCD1Dasatinib Tablets Rx Only These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. Initial U.S. Approval: 200620251118
645fcf26-1b2f-40c5-881b-8effe02defbddasatinib 50 MG Oral TabletPSN1These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS DASATINIB tablets, for oral use Initial U.S. Approval: 200620251112
645fcf26-1b2f-40c5-881b-8effe02defbddasatinib 50 MG Oral TabletSCD1These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS DASATINIB tablets, for oral use Initial U.S. Approval: 200620251112
4eed6b7b-a09d-4d2e-a345-968dd68323bcdasatinib 50 MG Oral TabletSCD1Dasatinib Tablets for Oral Use20250304
4eed6b7b-a09d-4d2e-a345-968dd68323bcdasatinib 50 MG Oral TabletPSN1Dasatinib Tablets for Oral Use20250304
11703145-29ea-480a-9810-bc70663b783fdasatinib 50 MG Oral TabletPSN1These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620240910
11703145-29ea-480a-9810-bc70663b783fdasatinib 50 MG Oral TabletSCD1These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620240910
58ce42c6-10bd-4bb4-bf89-eae8ed82c339dasatinib 50 MG Oral TabletSCD1These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620240803
58ce42c6-10bd-4bb4-bf89-eae8ed82c339dasatinib 50 MG Oral TabletPSN1These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 200620240803